The advanced infusion system market is projected to be valued at USD 8,862.8 million in 2023 and is expected to rise to USD 16,536.9 million by 2033. The sales of advanced infusion systems are expected to record a significant CAGR of 6.4% during the forecast period.
There is increased adoption of advanced infusion systems as these systems are being widely used to dispense fluids as well as drugs into a patient’s body for medication purposes. The common routes through which fluids are transferred with the help of an infusion system are subcutaneous, epidural or enteral, and intravenous.
The flow of drugs can be monitored and as well controlled with the help of advanced infusion systems. Due to high mortality rates associated with other methods of drug administration, the preference for advanced infusion systems is considerably increasing.
Therefore, it is anticipated that global advanced infusion systems are likely to have significant growth over the forecast period.
| Attributes | Details |
|---|---|
| Advanced Infusion System Market CAGR | 6.4% |
| Advanced Infusion System Market Valuation (2023) | USD 8,862.8 million |
| Advanced Infusion System Market Valuation (2033) | USD 16,536.9 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Many factors are identified within the advanced infusion systems forum that are likely to contribute to the expansion of the market size. Despite these influential factors, several challenges have also been identified by the experts of FMI during analysis.
DRIVERS
| Factors | Description |
|---|---|
| The Rise in Chronic Diseases | It is anticipated that there are rising incidences of cardiovascular diseases and chronic diseases leading to diabetes, which Is the prime driving factor in the advanced infusion systems market. |
| Increasing Healthcare Facilities | Many investments are being made within the healthcare sector that largely contribute to the growth of the advanced infusion system market. Gastronomical diseases, cancer, and other diseases catalyze the market's development. |
RESTRAINTS
| Factors | Description |
|---|---|
| Rising Concern about Safety | The improper disposable infusion pumps and the rising concerns about the safety of patients are leading to create several consequences, and the unmet medical needs in low-income countries are likely to hamper the growth of the global advanced infusion system market. |
| Lack of Expertise | It is anticipated that there are risks associated with the systems due to improper training facilities to operate these devices, which is likely to act as a significant restraint in the advancement of the concerned market. |
OPPORTUNITIES
| Factors | Description |
|---|---|
| Benefits of Intravenous Infusion System | The benefit of the intravenous infusion system in administering medication, amino acids, minerals, and several essential micronutrients can create opportunities infusion system market by adding to the infusion for collateral nutrition. |
| Technological Advances | Smart infusion systems are technologically advanced with automation, drug libraries, operators, and safety features for accurate and precise results for patients. It also helps in delivering controlled fluids into the patient systems. |
THREATS
| Factors | Description |
|---|---|
| Stringent Regulations | The stringent regulation of governments for launching new device approval is the key factor that poses a threat to the advanced infusion systems market during the forecast period. |
Let’s take a stroll across the drivers, restraints, opportunities, and threats (Drivers, Restraints, Opportunities, and Threats) prevailing in the advanced infusion systems market.
North America is likely to hold the maximum share and dominate the global advanced infusion system market in the coming years. Currently, the North American Regions are cumulatively holding 33.5% of the total market share of advanced infusion systems.
The reasons for expanding market size can be attributed to:
High adoption of ambulatory pumps in managing chronic diseases, there is a high prevalence of rising penetration of advanced infusion systems in this region.
The rising healthcare infrastructure in North America is also expected to significantly contribute to the growth and expansion of the market in this region.
Europe is anticipated to follow the North American market and hold the second-leading share in the global advanced infusion system market. At present, Europe is accountable for 32.1% of the total market share for advanced infusion systems.
The expansion of the market can be attributed to the factors like:
The vast patient population and the increasing incidence of chronic diseases bolstered the market growth for advanced infusion systems in North America.
Changing lifestyles coupled with increasing accessibility to advanced products and rising disposable income is another crucial factor influencing the market in Europe.
Principal Consultant
The volumetric infusion system holds a significant share of 34.70% in the advanced infusion system market. Volumetric infusion systems are widely used in healthcare settings to deliver precise and controlled volumes of fluids and medications to patients. These systems utilize advanced technology and features to measure and administer fluids accurately, ensuring patient safety and effective therapy.
The volumetric infusion system market encompasses various devices, including electronic volumetric pumps and syringe pumps used in hospitals, clinics, and other medical facilities. The growing demand for accurate and reliable infusion delivery, particularly in critical care and complex medical procedures, has contributed to the prominence of volumetric infusion systems in the advanced market.
These systems offer programmable flow rates, advanced safety features, intuitive user interfaces, and integration with electronic health records (EHRs) for seamless data management.
Hospitals are likely to account for more than 38.39% of the market share by end users in 2022.
Advanced infusion systems play a vital role in hospital settings, where accurate and controlled delivery of fluids and medications is crucial for patient care. These systems are extensively used in various hospital departments, including intensive care units, operating rooms, emergency departments, and general wards. Several factors drive the demand for advanced infusion systems in hospitals.
The increasing prevalence of chronic diseases, the rise in complex medical procedures, and the growing elderly population contribute to the need for advanced infusion therapy in hospitals. Additionally, technological advancements and the integration of smart features in infusion systems enhance their usability, safety, and efficiency in hospital environments.
Advanced infusion systems in hospitals offer benefits such as programmable flow rates, dose calculations, drug library management, wireless connectivity, and real-time monitoring capabilities. These features enable healthcare professionals to deliver medications and fluids accurately, track infusion parameters, and ensure patient safety.
As hospitals strive to improve patient outcomes and streamline healthcare processes, the demand for advanced infusion systems is expected to continue to grow, solidifying their significant share in the advanced infusion system market
Key Market Players Adding an Edge with Diverse Attempts
The biggies of the advanced infusion system market are continually making efforts and having collaborations to create high-end infusion systems and benefit the patients with more equipped and advanced solutions.
Recent Developments
In January 2020, Medtronic (Ireland) Launched Efficio, a cloud-based data management software, for use with the SynchroMed II intrathecal drug delivery system. This enables clinicians to efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer, and severe spasticity.
In March 2020, Q Core Medical Company opened a new manufacturing unit in Europe to capitalize on the opportunities offered by the advanced infusion systems market due to the increasing geriatric population and increasing demand for the adoption of infusion systems in healthcare, therapeutic effectiveness, and reliability.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD billion for Value |
| Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa, and South Africa |
| Key Segments Covered | Product, Application, End User, Region |
| Key Companies Profiled | TERUMO CORPORATION; AIS HealthCare; B. Braun Medical Ltd; Medtronic; Baxter; MOOG INC.; armed ag; AVA Biomedical; BD; Smiths Group plc. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at USD 8,862.8 million in 2023.
Volumetric infusion system is likely to remain preferred through 2033.
The primary consumer for advanced infusion systems is hospitals.
The global market size to reach USD 16,536.9 million by 2033.
Collaboration is going to be players’ key strategy to develop high-end infusion systems.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Elastomeric infusion system 5.2. Volumetric infusion system 5.3. Patient Controlled Analgesia pump 5.4. Disposable infusion system 5.5. Syringe infusion system 5.6. Ambulatory infusion system 5.7. Implantable infusion system 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Chemotherapy 6.2. Diabetes 6.3. Pain management 6.4. Asthma 6.5. Clinical Nutrition 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 7.1. Hospitals 7.2. Ambulatory Surgical Centers 7.3. Diagnostic centers 7.4. Bedside 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. TERUMO CORPORATION 18.2. AIS HealthCare 18.3. B. Braun Medical Ltd 18.4. Medtronic 18.5. Baxter 18.6. MOOG INC. 18.7. armed ag 18.8. AVA Biomedical 18.9. BD 18.10. Smiths Group plc. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Advanced Infusion Systems Market
